FDA Inspection 906518 — Rosemont Pharmaceuticals Ltd.

Rosemont Pharmaceuticals Ltd. — FEI 3002442738

The FDA completed an inspection of Rosemont Pharmaceuticals Ltd. on Dec 12, 2014 in Leeds. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 12, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Leeds (United Kingdom)

Citations

IDCFRDescription
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.